Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) have received a consensus recommendation of "Hold" from the thirty-five ratings firms that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, twenty-one have given a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $54.59.
Several analysts have recently issued reports on TDOC shares. Berenberg Bank lowered shares of Teladoc Health from a "buy" rating to a "hold" rating and reduced their target price for the stock from $42.00 to $35.00 in a research note on Tuesday, August 2nd. Needham & Company LLC lowered shares of Teladoc Health from a "buy" rating to a "hold" rating in a research note on Thursday, July 28th. Piper Sandler reduced their price target on shares of Teladoc Health from $42.00 to $40.00 and set an "overweight" rating for the company in a research report on Thursday, July 28th. DA Davidson began coverage on shares of Teladoc Health in a research report on Friday, August 12th. They set a "buy" rating and a $45.00 price target for the company. Finally, Cowen lowered shares of Teladoc Health from an "outperform" rating to a "market perform" rating and reduced their price target for the company from $58.00 to $34.00 in a research report on Tuesday, August 2nd.
Get Teladoc Health alerts:Insider Buying and Selling at Teladoc Health
In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of the stock in a transaction that occurred on Monday, July 18th. The shares were sold at an average price of $41.12, for a total transaction of $41,120.00. Following the transaction, the senior vice president now directly owns 27,408 shares in the company, valued at $1,127,016.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Arnnon Geshuri sold 4,098 shares of the firm's stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $34.27, for a total value of $140,438.46. Following the transaction, the insider now owns 76,182 shares in the company, valued at $2,610,757.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Daniel Trencher sold 1,000 shares of the firm's stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $41.12, for a total transaction of $41,120.00. Following the completion of the transaction, the senior vice president now owns 27,408 shares in the company, valued at approximately $1,127,016.96. The disclosure for this sale can be found here. Insiders have sold 7,318 shares of company stock worth $255,321 over the last ninety days. Insiders own 1.55% of the company's stock.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in TDOC. McCarthy Asset Management Inc. bought a new position in shares of Teladoc Health in the first quarter worth approximately $25,000. DB Wealth Management Group LLC purchased a new stake in Teladoc Health in the first quarter worth $25,000. City State Bank purchased a new stake in Teladoc Health in the fourth quarter worth $27,000. Oliver Lagore Vanvalin Investment Group purchased a new stake in Teladoc Health in the first quarter worth $27,000. Finally, SeaCrest Wealth Management LLC purchased a new stake in Teladoc Health in the second quarter worth $28,000. Institutional investors own 92.46% of the company's stock.Teladoc Health Stock Performance
Shares of TDOC stock opened at $26.23 on Friday. Teladoc Health has a 12 month low of $25.95 and a 12 month high of $156.82. The company has a current ratio of 3.38, a quick ratio of 3.22 and a debt-to-equity ratio of 0.25. The firm has a market capitalization of $4.23 billion, a PE ratio of -0.43 and a beta of 0.86. The firm has a fifty day simple moving average of $33.75 and a two-hundred day simple moving average of $41.67.
Teladoc Health (NYSE:TDOC – Get Rating) last posted its earnings results on Wednesday, July 27th. The health services provider reported ($0.44) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.71) by $0.27. Teladoc Health had a negative net margin of 441.94% and a negative return on equity of 2.04%. The firm had revenue of $592.38 million during the quarter, compared to analyst estimates of $586.86 million. Analysts forecast that Teladoc Health will post -1.54 EPS for the current fiscal year.
Teladoc Health Company Profile
(Get Rating)
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
See Also
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- Humana Proves Vertically Integrated Healthcare Works
- 2 Casino Stocks Worth Taking a Look At
- This Small-Cap Healthcare Name Is Outperforming Its Index
- What Cintas Can Teach Investors About This Bear Market?
- Blackberry Stock Declines As Results Come In Lukewarm Once Again
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.